GLP-1 receptor agonist and SGLT2 inhibitor prescribing in people with type 1 diabetes
Li P, Li Z, Staton E, et al.
JAMA. 2024:e2418581.
Leggi
Li P, Li Z, Staton E, et al.
JAMA. 2024:e2418581.
Leggi
Muscogiuri G, Barrea L, Bettini S, et al.
Obes Facts. 2024:1-37.
Leggi
Nathanson D, Eeg-Olofsson K, Spelman T, et al.
Diabetologia. Pub. online 26 Oct 2024.
Leggi
Lipska KJ, Gilliam LK, Lee C, et al.
Diabetes Care. 2024:dc241612.
Leggi
Ogurtsova K, Laxy M, Emmert-Fees K, et al.
BMJ Open Diabetes Res Care. 2024;12(5):e004382.
Leggi
Fan X, Liu Y, Chen X, et al.
Diabetes Obes Metab. Pub. online 21 Oct 2024.
Leggi
Friis Bryde Nielsen C, Møller Thysen S, Bach Kampmann F, et al.
Diabetes Obes Metab. Pub. online 21 Oct 2024.
Leggi
Andersen LL, Calatayud J, Núñez-Cortés R, et al. Diabetes Obes Metab. Pub. online 23 Oct 2024. Abstract
Leggi
Zhang L, Shen Y, Liu H, et al.
Diabetes Obes Metab. Pub. online 21 Oct 2024.
Leggi
Sommer J, Borgmann SO, Gontscharuk V, et al.
Lancet Diabetes Endocrinol. Pub. online 24 Oct 2024.
Leggi